References
- Mark EJ, Patalas ED, Chang HT, et al: Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N Engl J Med 1997; 337(9):602–606
- Abenhaim L, Moride Y, Brenot F, et al: Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996; 335(9): 609–616
- Connolly HM, Crary JL, McGoon MD, et al: Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337(9):581–585
- Graham DJ, Green L: Further cases of valvular heart disease associated with fenfluramine-phentermine, letter. N Engl J Med 1997; 337(9):635
- Centers for Disease Control and Prevention: Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations, November 1997. MMWR 1997:46(45):1061–1066
- Anchors M: Safer Than Phen-fen. Rockiin, CA, Prima Publishing, 1997